Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Case report of Usutu virus infection in an immunocompromised patient in Italy, 2022.
Gaibani P, Barp N, Massari M, Negri EA, Rossini G, Vocale C, Trenti C, Gallerani A, Cantergiani S, Romani F, Simion M, Mussini C, Lazzarotto T. Gaibani P, et al. Among authors: lazzarotto t. J Neurovirol. 2023 Jun;29(3):364-366. doi: 10.1007/s13365-023-01148-w. Epub 2023 May 25. J Neurovirol. 2023. PMID: 37227671 Free PMC article.
Environmental Contamination by SARS-CoV-2 During Noninvasive Ventilation in COVID-19.
Dell'Olio A, Vocale C, Primavera A, Pisani L, Altavilla S, Roncarati G, Tumietto F, Viale P, Re MC, Lazzarotto T, Nava S, Ranieri VM, Tonetti T. Dell'Olio A, et al. Among authors: lazzarotto t. Respir Care. 2023 Jan;68(1):1-7. doi: 10.4187/respcare.10323. Epub 2022 Nov 15. Respir Care. 2023. PMID: 36379641 Free PMC article.
Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase.
Bovo F, Amadesi S, Palombo M, Lazzarotto T, Ambretti S, Gaibani P. Bovo F, et al. Among authors: lazzarotto t. JAC Antimicrob Resist. 2023 Aug 17;5(4):dlad099. doi: 10.1093/jacamr/dlad099. eCollection 2023 Aug. JAC Antimicrob Resist. 2023. PMID: 37600494 Free PMC article.
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
Rescigno M, Agrati C, Salvarani C, Giannarelli D, Costantini M, Mantovani A, Massafra R, Zinzani PL, Morrone A, Notari S, Matusali G, Pinter GL, Uccelli A, Ciliberto G, Baldanti F, Locatelli F, Silvestris N, Sinno V, Turola E, Lupo-Stanghellini MT, Apolone G; VAX4FRAIL study Group. Rescigno M, et al. Front Immunol. 2023 Jan 27;14:1104124. doi: 10.3389/fimmu.2023.1104124. eCollection 2023. Front Immunol. 2023. PMID: 36776853 Free PMC article.
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection.
Pasquini Z, Toschi A, Casadei B, Pellegrini C, D'Abramo A, Vita S, Beccacece A, Bussini L, Chionsini MC, Dentale N, Cantiani A, Lazzarotto T, Bartoletti M, Nicastri E, Zinzani P, Giannella M, Viale P. Pasquini Z, et al. Among authors: lazzarotto t. Hematol Oncol. 2023 Dec;41(5):904-911. doi: 10.1002/hon.3206. Epub 2023 Jul 15. Hematol Oncol. 2023. PMID: 37452579
277 results